Cardioxyl Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
Cardioxyl Pharmaceuticals. is leveraging its nitroxyl chemistry platform to develop drugs for unmet cardiovascular conditions. Its lead product just entered Phase I/II trials for acute decompensated heart failure.